Fengling Wang

3.1k total citations
124 papers, 2.2k citations indexed

About

Fengling Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Fengling Wang has authored 124 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 24 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Fengling Wang's work include Natural product bioactivities and synthesis (8 papers), Nanoparticle-Based Drug Delivery (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Fengling Wang is often cited by papers focused on Natural product bioactivities and synthesis (8 papers), Nanoparticle-Based Drug Delivery (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Fengling Wang collaborates with scholars based in China, United States and Pakistan. Fengling Wang's co-authors include Shaoping Ji, Adil J. Nazarali, Weidong Chen, Liangzhi Xia, Zhengwei Xie, Weidong Chen, Ling Li, Yuan Huang, Lijia Li and Jingjing Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Fengling Wang

121 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengling Wang China 27 891 399 315 245 232 124 2.2k
Mohamed El‐Tanani United Kingdom 40 1.9k 2.1× 415 1.0× 657 2.1× 434 1.8× 769 3.3× 185 4.5k
Liping Deng China 30 846 0.9× 307 0.8× 135 0.4× 197 0.8× 203 0.9× 142 2.4k
Xiaoyan Lv China 28 1.3k 1.4× 224 0.6× 743 2.4× 252 1.0× 126 0.5× 96 3.2k
Xiufeng Zhang China 26 1.1k 1.2× 152 0.4× 179 0.6× 71 0.3× 167 0.7× 137 1.9k
Jing Feng China 24 894 1.0× 242 0.6× 302 1.0× 220 0.9× 158 0.7× 123 2.3k
Eunjung Kim South Korea 34 2.0k 2.2× 349 0.9× 1.1k 3.5× 539 2.2× 156 0.7× 138 3.5k
Ying Zhong China 23 478 0.5× 141 0.4× 332 1.1× 100 0.4× 59 0.3× 98 1.7k
Yan Dong China 22 518 0.6× 213 0.5× 181 0.6× 69 0.3× 297 1.3× 113 1.4k
Rui Sun China 24 825 0.9× 202 0.5× 489 1.6× 499 2.0× 201 0.9× 86 2.0k
Zhiqing Liu China 33 1.7k 1.9× 113 0.3× 371 1.2× 158 0.6× 281 1.2× 172 3.5k

Countries citing papers authored by Fengling Wang

Since Specialization
Citations

This map shows the geographic impact of Fengling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengling Wang more than expected).

Fields of papers citing papers by Fengling Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengling Wang. The network helps show where Fengling Wang may publish in the future.

Co-authorship network of co-authors of Fengling Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Fengling Wang. A scholar is included among the top collaborators of Fengling Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengling Wang. Fengling Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Zhuo, et al.. (2025). Promising TNF-α inhibitors: Targeting pathogenic TNF-α/TNFR signaling to restore Th17/Treg balance in rheumatoid arthritis. Journal of Pharmaceutical Analysis. 16(3). 101382–101382. 1 indexed citations
2.
Yang, Yujie, et al.. (2024). Case fatality rates of COVID‐19 during epidemic periods of variants of concern: A meta-analysis by continents. International Journal of Infectious Diseases. 141. 106950–106950. 15 indexed citations
3.
Hou, Zhen, et al.. (2024). Light-driven rotary polypyrrole/agar composite films. Journal of Materials Chemistry C. 12(12). 4453–4459. 3 indexed citations
4.
Wang, Ren, et al.. (2024). A Survey on Privacy Attacks and Defenses in Graph Neural Networks. Information Technology And Control. 53(4). 1251–1278. 1 indexed citations
5.
Wang, Fengling, Yong Huang, J Li, Weilin Zhou, & Wei Wang. (2024). Targeted gene delivery systems for T-cell engineering. Cellular Oncology. 47(5). 1537–1560. 5 indexed citations
6.
Yin, Zhe, Jin Zhang, Dakang Hu, et al.. (2023). Genomic analysis of chromosomal cointegrated blaNDM-1-carrying ICE and blaRSA-1-carrying IME from clinical multidrug resistant Aeromonas caviae. Frontiers in Cellular and Infection Microbiology. 13. 1131059–1131059. 3 indexed citations
7.
Gong, L., Junbo Xie, Yi Luo, et al.. (2023). Research progress of quality control for the seed of Ziziphus jujuba var. spinosa (Bunge) Hu ex H.F. Chow (Suan-Zao-Ren) and its proprietary Chinese medicines. Journal of Ethnopharmacology. 307. 116204–116204. 9 indexed citations
8.
Zhou, Min, Wenjing Lai, Rufu Xu, et al.. (2023). A celastrol-based nanodrug with reduced hepatotoxicity for primary and metastatic cancer treatment. EBioMedicine. 94. 104724–104724. 18 indexed citations
9.
Wang, Fengling, Saadullah Khattak, Muhammad Usman Akbar, et al.. (2022). Define the Two Molecular Subtypes of Epithelioid Malignant Pleural Mesothelioma. Cells. 11(18). 2924–2924. 4 indexed citations
10.
Niu, Qi, Weihua Liu, Fengling Wang, & YanHong Dong. (2022). Prevalence and factors associated with cognitive impairment in Chinese heart failure patients: A pilot study. Frontiers in Cardiovascular Medicine. 9. 978432–978432. 3 indexed citations
12.
Wang, Qiang, Yang An, Fengling Wang, et al.. (2020). OSchol: an online consensus survival web server for cholangiocarcinoma prognosis analysis. HPB. 23(4). 545–550. 2 indexed citations
13.
Wang, Fengling, Dongguo Wang, Wei Hou, et al.. (2019). Evolutionary Diversity of Prophage DNA in Klebsiella pneumoniae Chromosomes. Frontiers in Microbiology. 10. 2840–2840. 10 indexed citations
14.
Chen, Shangjun, et al.. (2018). Long noncoding RNA lncARSR promotes hepatic cholesterol biosynthesis via modulating Akt/SREBP-2/HMGCR pathway. Life Sciences. 203. 48–53. 37 indexed citations
15.
Wang, Haiyang, et al.. (2015). Three New Isomeric Indole Alkaloids from Nauclea officinalis. Chemistry & Biodiversity. 12(8). 1256–1262. 13 indexed citations
16.
Bing, Zhitong, Guanghui Yang, Yanan Zhang, et al.. (2014). Proteomic analysis of effects by x-rays and heavy ion in HeLa cells. Radiology and Oncology. 48(2). 142–154. 12 indexed citations
17.
18.
Wang, Fengling, Zhitong Bing, Yanan Zhang, et al.. (2013). Quantitative proteomic analysis for radiation-induced cell cycle suspension in 92-1 melanoma cell line. Journal of Radiation Research. 54(4). 649–662. 11 indexed citations
19.
Wang, Fengling. (2012). Influential factors on the establishment of experimental diabetic nephropathy in rats. Anhui Medical and Pharmaceutical Journal. 1 indexed citations
20.
Elder, Melissa E., Suzanne Skoda‐Smith, Theresa A. Kadlecek, et al.. (2001). Distinct T Cell Developmental Consequences in Humans and Mice Expressing Identical Mutations in the DLAARN Motif of ZAP-70. The Journal of Immunology. 166(1). 656–661. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026